- Use of herbal dopamine mimetics in adolescents and young women with menstrual irregularities
Use of herbal dopamine mimetics in adolescents and young women with menstrual irregularities
HEALTH OF WOMAN. 2017.10(126):43–49
Kuznetsova I. V., Uspenskaya Yu. B., DiL V. V., Grineva A. M.
SIC HBOU HPE The first Moscow State Medical University ІM. Sechenova, Russia
Obstetrics and Gynecology, № 10/2015
Functional impairments of the menstrual cycle constitute a significant proportion in the pattern of gynecological diseases in adolescents and young women. Non-hormonal correction is one of the leading therapies of these impairments.
The objective: to evaluate the efficiency of using a Vitex agnus-castus-containing drug in adolescents and young women with menstrual irregularities.
Materials and methods. The open-label randomized comparative trial enrolled 80 adolescents and young women with functional impairments of the menstrual cycle who were randomized into two groups receiving Cyclodynon® (a study group) or a multivitamin complex (a control group) for 6 months.
Results. The use of Cyclodynon® was found to shorten intermenstrual intervals and to improve acyclic bleeding control in patients with oligomenorrhea, to significantly reduce the degree of mastalgia, to improve autonomic function, and to normalize prolactin secretion.
Conclusion. The administration of Cyclodynon® may be regarded as a therapy option in patients with functional menstrual cycle impairments presumptively associated with disorders of prolactin secretion.
Key words: hyperprolactinemia, oligomenorrhea, amenorrhea, hypothalamic dysfunction, anovulation, mastalgia, Vitex agnus-castus, Cyclodynon®.
1.Sharapova OV ed. 2011. Adolescent Health. Guide for physicians. St. Petersburg:436.
2. Leschenko OYa. 2012. Feeding habits of modern senior pupils and students on materials survey. Reproduktivnoe zdorove detey i podrostkov 4:89–95.
3. Gurkin YuA. 2009. Pediatric and Adolescent Gynecology. Moscow, MIA:57.
4. Uvarova EV. 2006. Reproductive Health Russian girls at the beginning of the XXI century. Akusherstvo i ginekologiya/Obstetrics and gynecology. App.: 21-30.
5. Ushakova GA, Elgina SI. 2006. Reproductive health of children and adolescents. Akusherstvo i ginekologiya/Obstetrics and gynecology 1:34–9.
6. Chan SS. 2012. Menstrual problems in adolescents and improving quality of life: the panasian experience. Int. J. Gynecol. Obstet. 119(Suppl.3):S176. https://doi.org/10.1016/S0020-7292(12)60094-0
7. Snisarenko EA, Pasman NM, Dudareva AV. 2006. Experience with Agnukaston in adolescent girls. Reproduktivnoe zdorove detey i podrostkov. 1:25–30.
8. Uvarova EV. 2005. New features of the drug Mastodinon in the practice of child gynecologist. Reproduktivnoe zdorove detey i podrostkov 2:21–4.
9. Shamina IV, Gudkova GV. 2014. An integrated approach to the problems of formation of reproductive function in girls. Ginekologiya 16(4):28-32.
10. Rosenfield RL, Ehrmann DA, Littlejohn EE. 2015. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J. Clin. Endocrinol. Metab. 100(4):1537–43. https://doi.org/10.1210/jc.2014-4290; PMid:25675386 PMCid:PMC4399308
11. Fourman LT, Fazeli PK. 2015. Neuroendocrine causes of amenorrhea – an update. J. Clin. Endocrinol. Metab. 100(3):812–24. https://doi.org/10.1210/jc.2014-3344; PMid:25581597 PMCid:PMC4333037
12. Yamamoto K, Okazaki A, Sakamoto Y, Funatsu M. 2009. The relationship between premenstrual symptoms, menstrual pain, irregular menstrual cycles, and psychosocial stress among Japanese college students. J. Physiol. Anthropol. 28(3):129–36. https://doi.org/10.2114/jpa2.28.129; PMid:19483374
13. ODonnell E, Goodman JM, Mak S, Harvey PJ. 2014. Impaired vascular function in physically active premenopausal women with functional hypothalamic amenorrhea is associated with low shear stress and increased vascular tone. J. Clin. Endocrinol. Metab. 99(5):1798–806. https://doi.org/10.1210/jc.2013-3398
14. Bethea CL, Phu K, Reddy AP, Cameron JL. 2013. The effect of short moderate stress on the midbrain corticotropin-releasing factor system in a macaque model of functional hypothalamic amenorrhea. Fertil. Steril. 100(4):1111–21. https://doi.org/10.1016/j.fertnstert.2013.05.052
15. Męczekalski B, Czyiyk A. 2015. Vitex Agnus Castus in the treatment of hyperprolactinemia and menstrual disorders – a case report. Pol. Merkur. Lekarski. 39(229):43–6.
16. Arentz S, Abbott JA, Smith CA, Bensoussan A. 2014. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/ amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement. Altern. Med. 14(1):511. https://doi.org/10.1186/1472-6882-14-511
17. Yavarikia P, Shahnazi M, Hadavand Mirzaie S, Javadzadeh Y, Lutfi R. 2013. Comparing the effect of mefenamic acid and vitex agnus on intrauterine device induced bleeding. J. Caring Sci. 2(3):245–54. PMid:25276733 PMCid:PMC4134154
18. Dinç T, Coşkun F. 2014. Comparison of fructus agni casti and flurbiprofen in the treatment of cyclic mastalgia in premenopausal women. Ulus. Cerrahi Derg. 30(1):34–8. PMid:25931888 PMCid:PMC4379787
19. Carmichael AR. 2008. Can Vitex Agnus castus be used for the treatment of mastalgia? What is the current evidence? Evid. Based Complement. Alternat. Med. 5(3):247–50. https://doi.org/10.1093/ecam/nem074; PMid:18830450 PMCid:PMC2529385
20. Khalilzadeh E, Vafaei Saiah G, Hasannejad H, Ghaderi A, Ghaderi S, Hamidian G et al. 2015. Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil. Avicenna J. Phytomed. 5(3):218–30. PMid:26101755 PMCid:PMC4469960
21. Rani A, Sharma A. 2013. The genus Vitex: a review. Pharmacogn. Rev. 7(14):188–98. https://doi.org/10.4103/0973-7847.120522; PMid:24347927 PMCid:PMC3841997